AHR and atopic eczema: The aryl hydrocarbon receptor (AhR)-related signaling pathway has emerged as a promising target for alleviating the symptoms of atopic dermatitis (AD), a chronic inflammatory skin disease characterized by epidermal barrier dysfunction and immune dysregulation [1].